[Apolipoprotein E4, a Genetic Risk Factor for Alzheimer's Disease]
- PMID: 31588049
- DOI: 10.11477/mf.1416201404
[Apolipoprotein E4, a Genetic Risk Factor for Alzheimer's Disease]
Abstract
Apolipoprotein E (APOE) is reported to be a strong genetic risk factor for Alzheimer's disease (AD), broadly contributing to the AD pathologies observed in most populations. However, it is difficult to explicate these AD pathologies based only on the known functions of APOE. In this review article, we revisited the histories and functions of APOE and also reviewed its recently elucidated the pleiotropic roles in the brain.
Similar articles
-
Definition of Late Onset Alzheimer's Disease and Anticipation Effect of Genome-Wide Significant Risk Variants: Pilot Study of the APOE e4 Allele.Neuropsychobiology. 2019;77(1):8-12. doi: 10.1159/000490739. Epub 2018 Aug 15. Neuropsychobiology. 2019. PMID: 30110694
-
APOE ε4: the most prevalent yet understudied risk factor for Alzheimer's disease.Alzheimers Dement. 2014 Nov;10(6):861-8. doi: 10.1016/j.jalz.2014.06.015. Epub 2014 Sep 10. Alzheimers Dement. 2014. PMID: 25217293 Review.
-
Does an Alzheimer's disease susceptibility gene influence the cognitive effects of cancer therapy?Pediatr Blood Cancer. 2014 Oct;61(10):1739-42. doi: 10.1002/pbc.24768. Epub 2013 Sep 17. Pediatr Blood Cancer. 2014. PMID: 24106134 Review.
-
Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.J Alzheimers Dis. 2018;61(2):553-560. doi: 10.3233/JAD-170777. J Alzheimers Dis. 2018. PMID: 29172001 Free PMC article.
-
Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.J Alzheimers Dis. 2016 Oct 4;54(3):913-922. doi: 10.3233/JAD-160373. J Alzheimers Dis. 2016. PMID: 27567841 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous